Natural Products : an Answer to Cardiovascular Complications / Aman B. Upaganlawar and Tanuj Joshi, editors.

Format:

Book

Contributor:

Upaganlawar, Aman B., editor.

Joshi, Tanuj, editor.

Series:

Natural Products and Therapeutics Series

Language:

English

Subjects (All):

Cardiovascular system--Diseases--Alternative treatment.

Cardiovascular system.

Dietary supplements.

Physical Description:

1 online resource (488 pages)

Edition:

First edition.

Place of Publication:

New York : Nova Science Publishers, Inc., [2024]

Summary:

"Our book gives a comprehensive insight on cardiovascular diseases, with emphasis on the role of natural products in these diseases. National as well as international authors have contributed to this book and shared their knowledge in this book. They have worked hard and with dedication. This book can prove to be a valuable asset for the general public as well as to researchers around the globe"-- Provided by publisher.

Contents:

Intro

Contents

Preface

Acknowledgement

Chapter 1

The Beneficial Roles of Natural Products in Disease Management

Abstract

Abbreviations

1. Introduction

1.1. Natural Products

1.2. History of NPs in Disease Management

1.2.1. Antibiotics

1.2.2. Antifungal Agent

1.2.3. Antitumor

1.2.4. Anticancer

1.3. Types and Sources of NPs

1.3.1. Plants

1.3.2. Animals

1.3.3. Microbes

1.3.4. Marine Species

2. Production and Quality Control of Natural Product

2.1. Innovative Methods for Using NPs in Drug Discovery

2.2. Genetics Contribution to the Development of NPs

2.3. Proteomics Significance in the Search for New NPs

2.4. Metabolomics Function in the Search for New Natural Product Drugs

2.5. Quality Control of Natural Products

3. NPs: Mechanisms of Action

3.1. Antimicrobials

1. Inhibition of Cell Wall Synthesis

2. Inhibition of Protein Synthesis

3. Inhibition of Some Metabolites

4. Inhibition of Fungal Cell Wall Inhibition

5. Antiviral Effects

3.2. Antiplatelet Properties of Natural Products

3.3. Anti-Inflammatory Activities of NPs

3.4. Anti-Cancer Activities of NPs

1. Curcumin

2. Resveratrol

3. Epigallocatechin gallate (EGCG)

4. Allicin

5. Emodin

3.5. Antidiabetic Activities of NPs

1. Ginseng

2. Bitter Melon

3. Coptis Chinensis

4. Fenugreek

5. Gymnema

4. Therapeutic Application of Natural Products

5. Natural Products: Beneficial Roles in Disease Management

6. Limitations of the Use of Natural Products in Disease Management

7. Advances of Natural Products in Disease Management

Conclusion

References

Chapter 2

Bioactive Natural Products in the Management of CVS Disorders

2. Natural Bioactive Compounds as Cardiovascular Médicine

2.1. Digitalis.

2.2. Rauvolfia serpentine

2.3. Monascus purpureus

2.4. Ephedra sinica

2.5. Gynostemma pentraphyllum

2.6. Ginkgo biloba

2.7. Ganoderma lucidum

2.8. Panax ginseng

2.9. Centella asiatica

2.10. Convallaria majalis

2.11. Allium cepa

Chapter 3

The Role of Alkaloids in the Management of Cardiovascular Disorders

2. Alkaloids as Cardiotonic Agents

2.1. Haemostyptic Activities of Alkaloids

2.2. Hypotensive Effects of Alkaloids

2.3. Cardioprotective and Antioxidant Effects of Alkaloids

2.4. Cardioprotection and Effects of Alkaloids on Lipid Profile

2.5. Alkaloids as Diuretics in the Management of High Blood Pressure

2.6. Cardiac Protection and Hepatoprotective Effects of Alkaloids

Chapter 4

The Potential Effects of Flavonoids in the Treatment of Cardiovascular Diseases

1.1. Plant Metabolites

1.1.1. Classification of Plant Metabolites

1.1.1.1. Primary Metabolites

1.1.1.2. Secondary Metabolites

1.1.2. Role of Metabolites

2. Epidemiology

3. Plant-Derived Molecules Used for CVD

4. Cardioprotective Potential of Plants

4.1. Cardioprotective Mechanisms

5. Flavonoids

5.1. Molecular Mechanisms of Flavonoids

5.1.1. Modulation of Gene Expression and Signaling Pathways

5.1.2. Interaction with Gut Microbiota

5.1.3. Flavonoid-Protein Interactions Directly

6. Flavonoids Improve Cardiac Function in Heart Failure (HF)

7. Flavonoids Classification with Chemical Structures

7.1. Flavones

7.2. Flavonols

7.2.1. Quercetin

7.2.2. Kaempferol

7.3. Flavan-3-ols

7.3.1. Epicatechin

7.3.2. Epigallocatechin-3-gallate

7.4. Flavanones

7.4.1. Naringenin

7.4.2. Hesperetin

7.5. Anthocyanidins.

7.6. Isoflavones

7.6.1. Diadzein

7.6.2. Genistein

7.7. Chalcones

8. Flavonoid's Impact on Hypertension

9. Bioavailability of Flavonoid

Chapter 5

Polyphenols in the Management

of Cardiovascular Diseases

Abréviations

2. Polyphenols and their Potential for Cardiovascular Diseases

2.1. Quercetin

2.2. Naringin

2.3. Resveratrol

2.4. Curcumin

2.5. Salvianolic Acid

Chapter 6

The Role of Plant Glycosides in Cardiovascular Diseases

2. Health Benefits of Glycosides in Cardiovascular Diseases

2.1. Digoxin

2.2. Ouabain

2.3. Quercetin Glycoside

2.4. Proscillaridine and Scillaridin

2.5. Peruvoside

2.6. Antiarin

2.7. Apigenin Glycoside

2.8. Catechin Glycoside

2.9. Ginkgo-Flavone Glycosides

2.10. Terminali arjuna Glycosides

Chapter 7

Natural Products in the Management of Diabetes Mellitus with Reference to Atherosclerosis

2. Diabetic Atherosclerosis: Defining Features

3. Diabetic-Atherosclerosis Pathogenesis

4. Plants and their Ingredients Used in the Treatment of Diabetic-Atherosclerosis

4.1. Allium Sativum

4.2. Carica Papaya

4.3. Trigonella Foenum Graecum

4.4. Catharanthus Roseus

4.5. Pterocarpus Marsupium

4.6. Ocimum Sanctum

4.7. Monascus Purpueus

4.8. Curcuma Longa

4.9. Berberis Vulgaris

4.10. Rhodiola Rosea

4.11. Ginkgo Biloba

4.12. Salvia Miltiorrhiza

4.13. Rehmannia Glutinosa

4.14. Paeonia Suffruticosa

4.15. Resveratrol

4.16. Ligusticum Striatum

4.17. Fisetin

4.18. Celastrol

Chapter 8

Natural Products in the Management of Myocardial Infarction and Reperfusion.

Abstract

1.1. Etiology

1.2. Epidemiology

2. Challenges of the Current Management of Myocardial Infarction and Reperfusion

2.1. Timing

2.2. Myocardial Reperfusion Injury

2.3. Comorbidity Effect

3. Natural Products: A Promising Approach

3.1. Types of Natural Products

3.2. Sources of Natural Products

3.3. Synthesis of Natural Products

4. Molecular Mechanism of Natural Product in the Management of Mi and Reperfusion

4.1. Anti-Inflammatory Agent

4.2. Anti-Apoptosis Agent

4.3. Anti-Fibrotic

4.4. Angiogenesis

4.5. Agents That Act on the Mitochondria Injury Pathway

4.6. Antioxidant

5. Advances in the Management of MI and Reperfusion

6. Need for Further Research

Chapter 9

Hypertension Management Using Natural Diuretics

2. Management of Hypertension and Disadvantages

2.1. Non-Pharmacological Means

2.1.1. Dietary Factors

2.1.2. Reduction in Salt Intake

2.1.3. Ceasing Alcohol Intake

2.1.4. Increase in Fibres, Fruits, and Vegetables

2.1.5. Dietary Approach to Stop Hypertension (DASH)

2.1.6. Weight Management

2.2. Pharmacological Approaches

2.2.1. Diuretics

2.2.2.1. Loop Diuretics

2.2.2.2. Thiazide Diuretics

2.2.2.3. Potassium Sparing Diuretics

2.2.3. Angiotensin Converting Enzyme Inhibitor

3. Side Effects of Available Drugs

4. What Are Natural Diuretics?

5. Herbs as Natural Diuretics

5.1. Lepidium Sativum

5.2. Euphorbia Thymifolia Linn

5.3. Achyranthes Aspera Linn

5.4. Bixa Orellana

5.5. Mangifera Indica

5.6. Taraxacum Officinale

5.7. Thespesia Populnea

5.8. Rungia Repens

5.9. Cuscuta Reflexa

5.10. Mimusops Elengi

Chapter 10.

The Ethnopharmacological Study of Nelumbo Nucifera: A Novel Therapeutic Approach in Cardiovascular Diseases

2. Nelumbo Nucifera

2.1. Physical Characteristics

2.2. Phytochemical Constituents

2.3. Health Benefits and Pharmacological activity

2.3.1. Anti-Oxidant

2.3.2. Anti-Platelet

2.3.3. Anti-Arrhythmic

2.3.4. Cardiovascular Activity

2.3.5. Anti-Inflammatory

2.3.6. Anti-Pyretic

3. Cardiovascular Diseases

3.1. Physiology of CVS

3.3. Types of Diseases

3.3.1. Coronary Artery Disease

3.3.2. Cardiac Arrhythmia

3.3.3. Congestive Heart Failure

3.3.4. Myocardial Infarction

3.3.5. Hypertension

4. Current Scenario of Heart Diseases and Stroke Statistics

5. Mechanism of Nelumbo Nucifera on Cardiovascular Diseases

5.1. Nelumbo Nucifera in Cardiac Arrhythmia

5.2. Nelumbo Nucifera in Hypertension

5.3. Nelumbo Nucifera in Coronary Artery Disease

Chapter 11

Medicinal Plants in the Management of Cardiac Arrhythmia

2. Adverse Drug Reaction of AADS

3. Plants and Their Ingredients with Anti-Arrhythmic Activities

3.1. Allium sativum (Garlic)

3.2. Arctium lappa (Greater Burdock)

3.3. Aloe vera

3.4. Bauhinia variegata (Camel's Foot)

3.5. Berberis vulgaris (Barberry)

3.6. Crocus sativus (Saffron)

3.7. Crataegus oxyacantha (Hawthorn)

3.8. Cinnamomum genus

3.9. Citrus bergamia (Bergamot)

3.10. Cynodon dactylon

3.11. Camellia oleifera

3.12. Corydalis yanhusuo

3.13. Camellia sinensis (Tea)

3.14. Dracocephalum moldavica (Moldavian Balm or Dragonhead)

3.15. Evodia rutaecarpa

3.16. Fluggea virosa (Chinese Waterberry)

3.17. Fissistigma glaucescens

3.19. Glycyrrhiza uralensis (Licorice)

3.19. Gynostemma pentaphyllum.

3.20. Ginkgo biloba.

Notes:

Description based on print version record.

Includes bibliographical references and index.

Other Format:

Print version: Upaganlawar, Aman B. Natural Products: an Answer to Cardiovascular Complications

ISBN:

979-88-911-3196-5